Clinical trial
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
NCT02312063
Study timeline
Study start (unknown)2015-02-01Date precision: month
Registry last updated2019-07-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
SitagliptinDRUG · verified · RxNorm: sitagliptin
GlimepirideDRUG · verified · RxNorm: glimepiride
Sponsors & collaborators
Kansai Electric Power Hospitallead sponsor
Saiseikai Noe Hospital Osakacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02312063 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.